Prof. Martin Votava

Chief Medical Officer

Martin is an expert in pharmacology and regulatory science.

He represented the Czech Republic in The Committee for Medicinal Products for Human Use at EMA (2007-2010), while working as the Head of the Preclinical and Clinical Documentation Assessment Unit at the State Institute for Drug Control.

He coordinated and provided assessment for centralized marketing authorization procedures and referrals as a rapporteur or a co-rapporteur for new active substances, biosimilar and generic medicinal products. In 2010, Martin co-founded PharmInvent, which was acquired by Ergomed in 2016.

Prof. Martin Votava gained his education in pharmacology at Charles University in Prague (MD, PhD, Prof. Assoc.), where he held the position as Head of the Pharmacology Department.